References
- Al-Hasan MN, Wilson JW, Lahr BD, Thomsen KM, Eckel-Passow JE, Vetter EA, Tleyjeh IM, Baddour LM. 2009. β-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 53(4):1386–1394. doi:https://doi.org/10.1128/AAC.01231-08.
- Cavaco LM, Hasman H, Xia S, Aarestrup FM. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother. 53(2):603–608. doi:https://doi.org/10.1128/AAC.00997-08.
- Colomer-Lluch M, Mora A, López C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M. 2013. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b: H4-B2-ST131 and O25b: H4-D-ST69 in raw sewage and river water in Barcelona, Spain. J Antimicrob Chemother. 68(4):758–765. doi:https://doi.org/10.1093/jac/dks477.
- Founou LL, Founou RC, Essack SY. 2016. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol. 7:1881. doi:https://doi.org/10.3389/fmicb.2016.01881.
- Gosling R, Clouting C, Randall L, Horton R, Davies R. 2012. Ciprofloxacin resistance in E. coli isolated from turkeys in Great Britain. Avian Pathol. 41(1):83–89. doi:https://doi.org/10.1080/03079457.2011.640659.
- Kao C-Y, Wu H-M, Lin W-H, Tseng -C-C, Yan -J-J, Wang M-C, Teng C-H, Wu -J-J. 2016. Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001–2015. Sci Rep. 6(1):32281. doi:https://doi.org/10.1038/srep32281.
- Kim ES, Hooper DC. 2014. Clinical importance and epidemiology of quinolone resistance. Infect & Chemother. 46(4):226–238. doi:https://doi.org/10.3947/ic.2014.46.4.226.
- Kim HB, Park CH, Kim CJ, Kim E-C, Jacoby GA, Hooper DC. 2009a. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 53(2):639–645. doi:https://doi.org/10.1128/AAC.01051-08.
- Kim HB, Wang M, Park CH, Kim E-C, Jacoby GA, Hooper DC. 2009b. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother. 53(8):3582–3584. doi:https://doi.org/10.1128/AAC.01574-08.
- Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. 2019. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 8(1):44. doi:https://doi.org/10.1186/s13756-019-0489-3.
- Liu B-T, Liao X-P, Yang -S-S, Wang X-M, Li -L-L, Sun J, Yang Y-R, Fang L-X, Li L, Zhao D-H. 2012. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals. J Med Microbiol. 61(11):1591–1599. doi:https://doi.org/10.1099/jmm.0.043307-0.
- Lo C-L, Lee -C-C, Li C-W, Li M-C, Hsueh P-R, Lee N-Y, Ko W-C. 2017. Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Microbiol Immunol Infect. 50(3):355–361. doi:https://doi.org/10.1016/j.jmii.2015.08.012.
- Mahon CR, Lehman DC, Manuselis G. 2014. Textbook of diagnostic microbiology-e-book. Elsevier Health Sciences. St. Louis, MO: Saunders.
- Margaritis A, Galani I, Chatzikonstantinou M, Petrikkos G, Souli M. 2017. Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat. J Med Microbiol. 66(3):266–275. doi:https://doi.org/10.1099/jmm.0.000397.
- Martínez-Martínez L, Pascual A, Jacoby GA. 1998. Quinolone resistance from a transferable plasmid. The Lancet. 351(9105):797–799. doi:https://doi.org/10.1016/S0140-6736(97)07322-4.
- Mirzaii M, Jamshidi S, Zamanzadeh M, Marashifard M, Hosseini SAAM, Haeili M, Jahanbin F, Mansouri F, Darban-Sarokhalil D, Khoramrooz SS. 2018. Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran. J Global Antimicrob Resist. 13:197–200. doi:https://doi.org/10.1016/j.jgar.2018.04.017.
- Morgan-Linnell SK, Boyd LB, Steffen D, Zechiedrich L. 2009. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother. 53(1):235–241. doi:https://doi.org/10.1128/AAC.00665-08.
- Muggeo A, Cambau E, Amara M, Micaëlo M, Pangon B, Bajolet O, Benmansour H, de Champs C, Guillard T. 2020. Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance. J Antimicrob Chemother. 75(9):2466–2470. doi:https://doi.org/10.1093/jac/dkaa189.
- Paltansing S, Kraakman M, Ras J, Wessels E, Bernards A. 2013. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother. 68(1):40–45. doi:https://doi.org/10.1093/jac/dks365.
- Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. 2006. Prevalence in the United States of aac (6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 50(11):3953–3955. doi:https://doi.org/10.1128/AAC.00915-06.
- Patel JB. 2017. Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute.
- Perez F, Rudin SD, Marshall SH, Coakley P, Chen L, Kreiswirth BN, Rather PN, Hujer AM, Toltzis P, Van Duin D. 2013. OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin. Antimicrob Agents Chemother. 57(9):4602–4603. doi:https://doi.org/10.1128/AAC.00725-13.
- Pishnian Z, Haeili M, Feizi A. 2019. Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran. Gut Pathog. 11(1):1–8. doi:https://doi.org/10.1186/s13099-019-0282-0.
- Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 70(1):119–123. doi:https://doi.org/10.1016/j.diagmicrobio.2010.12.002.
- Redgrave LS, Sutton SB, Webber MA, Piddock LJ. 2014. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 22(8):438–445. doi:https://doi.org/10.1016/j.tim.2014.04.007.
- Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. 2006a. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 12(1):83–88. doi:https://doi.org/10.1038/nm1347.
- Robicsek A, Strahilevitz J, Sahm D, Jacoby G, Hooper D. 2006b. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 50(8):2872–2874. doi:https://doi.org/10.1128/AAC.01647-05.
- Röderova M, Halova D, Papousek I, Dolejska M, Masarikova M, Hanulik V, Pudova V, Broz P, Htoutou-Sedlakova M, Sauer P. 2017. Characteristics of quinolone resistance in Escherichia coli isolates from humans, animals, and the environment in the Czech Republic. Front Microbiol. 7:2147. doi:https://doi.org/10.3389/fmicb.2016.02147.
- Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A. 2011. Plasmid-mediated quinolone resistance: an update. J Infect Chemother. 17(2):149–182.
- Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 22(4):664–689. doi:https://doi.org/10.1128/CMR.00016-09.
- Wong MHY, Chan EWC, Chen S. 2015. Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother. 59(6):3290–3297. doi:https://doi.org/10.1128/AAC.00310-15.
- Xue G, Li J, Feng Y, Xu W, Li S, Yan C, Zhao H, Sun H. 2017. High prevalence of plasmid-mediated quinolone resistance determinants in Escherichia coli and Klebsiella pneumoniae isolates from pediatric patients in China. Microb Drug Resist. 23(1):107–114. doi:https://doi.org/10.1089/mdr.2016.0004.
- Yamane K, J-i W, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, Arakawa Y. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 51(9):3354–3360. doi:https://doi.org/10.1128/AAC.00339-07.
- Yoshida H, Bogaki M, Nakamura M, Nakamura S. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 34(6):1271–1272. doi:https://doi.org/10.1128/AAC.34.6.1271.
- Zhao L, Zhang J, Zheng B, Wei Z, Shen P, Li S, Li L, Xiao Y. 2015. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals. J Clin Microbiol. 53(3):766–770. doi:https://doi.org/10.1128/JCM.02594-14.
- Zhao X, Xu X, Zhu D, Ye X, Wang M. 2010. Decreased quinolone susceptibility in high percentage of Enterobacter cloacae clinical isolates caused only by Qnr determinants. Diagn Microbiol Infect Dis. 67(1):110–113. doi:https://doi.org/10.1016/j.diagmicrobio.2009.12.018.
- Zurfluh K, Abgottspon H, Hächler H, Nüesch-Inderbinen M, Stephan R. 2014. Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One. 9(4):e95864. doi:https://doi.org/10.1371/journal.pone.0095864.